Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care – The BMJ

Conclusions –  There are clinically important differences in risk of cardiovascular disease, heart failure, and all cause mortality between different diabetes drugs alone and in combination. Overall, use of gliptins or glitazones was associated with decreased risks of heart failure, cardiovascular disease, and all cause mortality compared with non-use of these drugs. These results, which do not account for levels of adherence or dosage information and which are subject to confounding by indication, might have implications for prescribing of diabetes drugs.

Source: Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care | The BMJ

Recurrent Diabetic Ketoacidosis Raises Mortality Risk in T1D – Medpage Today

Recurrent episodes of diabetic ketoacidosis (DKA) were associated with a substantially increased risk of death in patients with type 1 diabetes, according to a retrospective single-center Scottish study.

Limitations of the study included its single-center design, which “does leave the generalizability of these results open to question,” Gibb and colleagues said.

Source: Recurrent Diabetic Ketoacidosis Raises Mortality Risk in T1D | Medpage Today